10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308 | -26.1% | 7,467 | 0.0% | 0.09% | -59.3% |
| Q2 2023 | $417 | 0.0% | 7,467 | 0.0% | 0.22% | +105.7% |
| Q1 2023 | $417 | -11.3% | 7,467 | -42.1% | 0.10% | +59.1% |
| Q4 2022 | $470 | -99.8% | 12,886 | +118.4% | 0.07% | -8.3% |
| Q2 2022 | $267,000 | -40.5% | 5,901 | 0.0% | 0.07% | -41.0% |
| Q1 2022 | $449,000 | -48.9% | 5,901 | 0.0% | 0.12% | -45.8% |
| Q4 2021 | $879,000 | +2.3% | 5,901 | 0.0% | 0.22% | -55.2% |
| Q3 2021 | $859,000 | -25.7% | 5,901 | 0.0% | 0.50% | +67.9% |
| Q2 2021 | $1,156,000 | +35.2% | 5,901 | +24.9% | 0.30% | +40.4% |
| Q1 2021 | $855,000 | +27.8% | 4,723 | 0.0% | 0.21% | +26.8% |
| Q4 2020 | $669,000 | +70.2% | 4,723 | +50.0% | 0.17% | +48.7% |
| Q3 2020 | $393,000 | – | 3,149 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |